Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer

NCT00604994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 761

Last updated 2013-08-20

No results posted yet for this study

Summary

This project will conduct a prospective, longitudinal, observational cohort study to assess the onset and incidence of lymphoedema, as well as investigate factors associated with its development among women newly diagnosed with gynaecological cancers in 2008 to 2011.

Conditions

Sponsors & Collaborators

  • The University of Queensland

    collaborator OTHER
  • Royal Brisbane and Women's Hospital

    collaborator OTHER_GOV
  • Mater

    collaborator OTHER
  • Mater Private Hospital

    collaborator OTHER
  • Queensland Institute of Medical Research

    collaborator OTHER
  • Queensland University of Technology

    collaborator OTHER
  • Australia New Zealand Gynaecological Oncology Group

    collaborator OTHER
  • Cancer Australia

    collaborator OTHER
  • Queensland Centre for Gynaecological Cancer

    lead OTHER_GOV

Principal Investigators

  • Andreas Obermair, MD FRANZCOG CGO · Queensland Centre for Gynaecological Cancer

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2013-01-31
Completion
2013-04-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00604994 on ClinicalTrials.gov